Akebia Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Akebia Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Akebia Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 130 %, a 55.7% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2023 was 179 %.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2022 was -397 %, a 111% decline from 2021.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2021 was -188 %, a 62.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 179 +576 Jan 1, 2023 Dec 31, 2023
2022 -397 -209 -111% Jan 1, 2022 Dec 31, 2022
2021 -188 -72.3 -62.4% Jan 1, 2021 Dec 31, 2021
2020 -116 -58.4 -102% Jan 1, 2020 Dec 31, 2020
2019 -57.5 -7.16 -14.2% Jan 1, 2019 Dec 31, 2019
2018 -50.3 +44.7 +47.1% Jan 1, 2018 Dec 31, 2018
2017 -95 +20.5 +17.8% Jan 1, 2017 Dec 31, 2017
2016 -116 -68.9 -148% Jan 1, 2016 Dec 31, 2016
2015 -46.6 -14.9 -47% Jan 1, 2015 Dec 31, 2015
2014 -31.7 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.